Theophylline Extended-release Tablets

Theophylline Extended-release Tablets
SPL v1
SPL
SPL Set ID 7339f98d-b996-4e20-a7a7-315fd2a9fa4d
Route
ORAL
Published
Effective Date 2024-05-22
Document Type 34391-3 HUMAN PRESCRIPTION DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
Theophylline Anhydrous (300 mg)
Inactive Ingredients
Hypromellose 2208 (100 Mpa.s) Lactose Monohydrate Magnesium Stearate Povidone

Identifiers & Packaging

Pill Appearance
Imprint: 7;29 Shape: capsule Color: white Size: 14 mm Size: 19 mm Score: 2
Marketing Status
ANDA Active Since 2024-05-25

Description

Theophylline extended-release tablets, 300 mg 100 Tablets NDC 70771-1782-1 Rx only Theophylline extended-release tablets, 450 mg 100 Tablets NDC 70771-1783-1 Rx only


Medication Information

Description

Theophylline extended-release tablets, 300 mg 100 Tablets NDC 70771-1782-1 Rx only Theophylline extended-release tablets, 450 mg 100 Tablets NDC 70771-1783-1 Rx only

Package Label.principal Display Panel

Theophylline extended-release tablets, 300 mg

100 Tablets

NDC 70771-1782-1

Rx only

Theophylline extended-release tablets, 450 mg

100 Tablets

NDC 70771-1783-1

Rx only


Structured Label Content

Package Label.principal Display Panel (PACKAGE LABEL.PRINCIPAL DISPLAY PANEL)

Theophylline extended-release tablets, 300 mg

100 Tablets

NDC 70771-1782-1

Rx only

Theophylline extended-release tablets, 450 mg

100 Tablets

NDC 70771-1783-1

Rx only


Advanced Ingredient Data


Raw Label Data

All Sections (JSON)